Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Associate Professor of Otolaryngology, Academy of Medical Sciences of IR Iran, Tehran, Iran.
Arch Iran Med. 2023 Mar 1;26(3):176-180. doi: 10.34172/aim.2023.27.
Genetic analysis of non-syndromic hearing loss (NSHL) has been challenged due to marked clinical and genetic heterogeneity. Today, advanced next-generation sequencing (NGS) technologies, such as exome sequencing (ES), have drastically increased the efficacy of gene identification in heterogeneous Mendelian disorders. Here, we present the utility of ES and re-evaluate the phenotypic data for identifying candidate causal variants for previously unexplained progressive moderate to severe NSHL in an extended Iranian family. Using this method, we identified a known heterozygous nonsense variant in exon 26 of the gene (MIM: 602121), which led to "Deafness, autosomal dominant 1, with or without thrombocytopenia; DFNA1" (MIM: 124900) in this large family in the absence of disease-causing variants and also OtoSCOPE-negative results. To the best of our knowledge, this nonsense variant (NM_001079812.3):c.3610C>T (p.Arg1204Ter) is the first report of the gene variant for autosomal dominant non-syndromic hearing loss (ADNSHL) in Iran.
由于显著的临床和遗传异质性,非综合征性听力损失(NSHL)的遗传分析一直具有挑战性。如今,先进的下一代测序(NGS)技术,如外显子组测序(ES),极大地提高了对异质性孟德尔疾病中基因识别的功效。在这里,我们展示了 ES 的实用性,并重新评估了表型数据,以确定先前无法解释的伊朗一个扩展家族中进行性中度至重度 NSHL 的候选因果变异。使用这种方法,我们在这个大家庭中发现了一个已知的杂合无义变异,位于 基因的外显子 26 中(MIM:602121),这导致了“常染色体显性 1 型耳聋,伴有或不伴有血小板减少症;DFNA1”(MIM:124900),而没有致病性变异,也没有 OtoSCOPE 阴性结果。据我们所知,这个无义变异(NM_001079812.3):c.3610C>T(p.Arg1204Ter)是伊朗首例报道的常染色体显性非综合征性听力损失(ADNSHL) 基因变异。